Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study).
Gómez-Ayerbe C, Palacios R, Mayorga M, Navarrete MN, Ferra S, Ruiz I, Garcia C, Castaño M, Merino D, Collado A, Hidalgo-Tenorio C, Delgado M, Rivero A, Santos J. Gómez-Ayerbe C, et al. Among authors: mayorga m. Int J STD AIDS. 2022 Nov;33(13):1119-1123. doi: 10.1177/09564624221125356. Epub 2022 Sep 7. Int J STD AIDS. 2022. PMID: 36071543
Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study.
Palacios R, Mayorga M, González-Domenech CM, Hidalgo-Tenorio C, Gálvez C, Muñoz-Medina L, de la Torre J, Lozano A, Castaño M, Omar M, Santos J. Palacios R, et al. Among authors: mayorga m. J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218760847. doi: 10.1177/2325958218760847. J Int Assoc Provid AIDS Care. 2018. PMID: 29529910 Free PMC article.
Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera®). Efficacy and safety analysis. GeSida Study 8114.
Pérez-Hernández IA, Palacios R, Mayorga M, González-Doménech CM, Castaño M, Rivero A, Del Arco A, Lozano F, Santos J. Pérez-Hernández IA, et al. Among authors: mayorga m. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19795. doi: 10.7448/IAS.17.4.19795. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397539 Free PMC article.
Lipid Changes in Virologically Suppressed HIV-Infected Patients Switching from any Antiretroviral Therapy to the Emtricitabine/Rilpivirine/Tenofovir Single Tablet: GeSida Study 8114.
Palacios R, Mayorga M, Pérez-Hernández IA, Rivero A, Arco AD, Lozano F, Santos J; GESIDA-8114-LIRA Study Group. Palacios R, et al. Among authors: mayorga m. J Int Assoc Provid AIDS Care. 2016 May;15(3):189-93. doi: 10.1177/2325957416629785. Epub 2016 Feb 8. J Int Assoc Provid AIDS Care. 2016. PMID: 26858314 Free article.
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study.
Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Casado A, Podzamczer D. Ocampo A, et al. Among authors: mayorga mi. J Antimicrob Chemother. 2018 Aug 1;73(8):2171-2176. doi: 10.1093/jac/dky175. J Antimicrob Chemother. 2018. PMID: 29788066 Free article.
Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub.
Jung SM, Loo SL, Howerton E, Contamin L, Smith CP, Carcelén EC, Yan K, Bents SJ, Levander J, Espino J, Lemaitre JC, Sato K, McKee CD, Hill AL, Chinazzi M, Davis JT, Mu K, Vespignani A, Rosenstrom ET, Rodriguez-Cartes SA, Ivy JS, Mayorga ME, Swann JL, España G, Cavany S, Moore SM, Perkins TA, Chen S, Paul R, Janies D, Thill JC, Srivastava A, Aawar MA, Bi K, Bandekar SR, Bouchnita A, Fox SJ, Meyers LA, Porebski P, Venkatramanan S, Adiga A, Hurt B, Klahn B, Outten J, Chen J, Mortveit H, Wilson A, Hoops S, Bhattacharya P, Machi D, Vullikanti A, Lewis B, Marathe M, Hochheiser H, Runge MC, Shea K, Truelove S, Viboud C, Lessler J. Jung SM, et al. Among authors: mayorga me. PLoS Med. 2024 Apr 17;21(4):e1004387. doi: 10.1371/journal.pmed.1004387. eCollection 2024 Apr. PLoS Med. 2024. PMID: 38630802 Free PMC article.
Evaluating the potential impact of rubella-containing vaccine introduction on congenital rubella syndrome in Afghanistan, Dem. Republic of Congo, Ethiopia, Nigeria, and Pakistan: A mathematical modeling study.
Rodriguez-Cartes SA, Zhang Y, Mayorga ME, Swann JL, Allaire BT. Rodriguez-Cartes SA, et al. Among authors: mayorga me. PLOS Glob Public Health. 2024 Jan 16;4(1):e0002656. doi: 10.1371/journal.pgph.0002656. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38227558 Free PMC article.
218 results